Temozolomide or Dacarbazine-based Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Endostatin (Primary) ; Temozolomide (Primary) ; Dacarbazine; Fluorouracil
- Indications Neuroendocrine carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 12 Apr 2017 Status changed from recruiting to completed.
- 05 Jan 2016 Primary end point has been revised.(Progression free survival to overall response rate) as reported by ClinicalTrials.gov record.